The Maryland Prescription Drug Affordability Board (PDAB) found that Eli Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga (dapagliflozin) present affordability ...

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

Adults who feel anxious on a Monday have greater long-term stress hormone levels, regardless of their working status, new research has highlighted. A recent study from the University of Hong Kong has ...